Beacon Biosignals raises $27 Million Series A led by General Catalyst to scale its EEG neurobiomarker discovery platform
Specialist venture capital house Mission BioCapital has raised $275m for its fifth flagship fundraise, more than double the amount it collected for its predecessor vehicle. The post Mission BioCapital more than doubles last fund total
Former Google Ventures CEO Bill Maris has seen his venture capital firm Section 32 strike a $740m final close for its fourth fund. The post Ex-Google Ventures CEO Maris sees Section 32 strike $740m Fund
Private equity funds soared to a record quarterly return at the start of this year amid a strong recovery of the global economy from the coronavirus pandemic, new data shows. The post Private equity, venture
Venture capital major New Enterprise Associates has brought in veteran life sciences investor Michele Park as a partner in its Menlo Park office. The post VC giant NEA brings in life sciences veteran Park as
Alternative protein investor Lever VC will launch a $250m-targeting Fund II raise in the first quarter next year, AltAssets has learned. If successful, it would be three times bigger than the firm’s inaugural fund. The
Having strengthened its senior team, venture capital firm HealthCap is looking ahead to a busy healthcare and life sciences market, co-managing partners Mårten Steen and Björn Odlander tell Unquote.
Notifications
Recent Comments